Search
for
Sort by
Research 871–900 of 1000+
- The Medical and Psychosocial Associations of Alopecia: Recognizing Hair Loss as More Than a Cosmetic Concern
- Three cases of immune‐mediated adnexal skin disease treated with cyclosporin
- Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata
- Treatment options for alopecia: an update, looking to the future
- Zinc in skin pathology and care
- CLINICAL AND LABORATORY EVALUATION OF AIDS TRICHOPATHY
- Alopecia Areata. Current situation and perspectives
- Concomitant Use of Hyaluronic Acid and Laser in Facial Rejuvenation
- Fractional resurfacing in the Asian patient: Current state of the art
- Madarosis
- Guidelines of care for superficial mycotic infectionsof the skin: Tinea capitis and tinea barbae
- Black women’s hair: the main scalp dermatoses and aesthetic practices in women of African ethnicity
- Hyperplasia of the Subcutaneous Adipose Tissue Is the Primary Histopathologic Abnormality in Lipedematous Scalp
- The Efficacy of Platelet-Rich Plasma in the Field of Hair Restoration and Facial Aesthetics—A Systematic Review and Meta-analysis
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Traction Alopecia
- Freeze-Drying of Platelet-Rich Plasma: The Quest for Standardization
- Immune modulation of hair follicle regeneration
- Frontal Fibrosing Alopecia: To Treat or Not to Treat?
- Adolescent hair loss
- Fatty acids and related lipid mediators in the regulation of cutaneous inflammation
- HAIR DISEASES
- iNKT cells ameliorate human autoimmunity: Lessons from alopecia areata
- Central Centrifugal Cicatricial Alopecia: New Insights and a Call for Action
- Platelet-Rich Plasma for the Aesthetic Surgeon
- Innovative Uses for Zinc in Dermatology
- Cicatricial marginal alopecia: is it all traction?
- Nonvascular Complications of Injectable Fillers—Prevention and Management
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening